Literature DB >> 21928074

Morphological aspects of neuromuscular junctions and gene expression of nicotinic acetylcholine receptors (nAChRs) in skeletal muscle of rats with heart failure.

Paula Aiello Tomé de Souza1, Selma Maria Michelin Matheus, Eduardo Paulino Castan, Dijon Henrique Salomé Campos, Antônio Carlos Cicogna, Robson Francisco Carvalho, Maeli Dal-Pai-Silva.   

Abstract

HF is syndrome initiated by a reduction in cardiac function and it is characterized by the activation of compensatory mechanisms. Muscular fatigue and dyspnoea are the more common symptoms in HF; these may be due in part to specific skeletal muscle myopathy characterized by reduced oxidative capacity, a shift from slow fatigue resistant type I to fast less fatigue resistant type II fibers and downregulation of myogenic regulatory factors (MRFs) gene expression that can regulate gene expression of nicotinic acetylcholine receptors (nAChRs). In chronic heart failure, skeletal muscle phenotypic changes could influence the maintenance of the neuromuscular junction morphology and nAChRs gene expression during this syndrome. Two groups of rats were studied: control (CT) and Heart Failure (HF), induced by a single intraperitoneal injection of monocrotaline (MCT). At the end of the experiment, HF was evaluated by clinical signs and animals were sacrificed. Soleus (SOL) muscles were removed and processed for morphological, morphometric and molecular NMJ analyses. Our major finding was an up-regulation in the gene expression of the alpha1 and epsilon subunits of nAChR and a spot pattern of nAChR in SOL skeletal muscle in this acute monocrotaline induced HF. Our results suggest a remodeling of nAChR alpha1 and epsilon subunit during heart failure and may provide valuable information for understanding the skeletal muscle myopathy that occurs during this syndrome.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21928074     DOI: 10.1007/s10735-011-9354-2

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  35 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Molecular architecture of the neuromuscular junction.

Authors:  Benjamin W Hughes; Linda L Kusner; Henry J Kaminski
Journal:  Muscle Nerve       Date:  2006-04       Impact factor: 3.217

3.  Heart failure alters MyoD and MRF4 expressions in rat skeletal muscle.

Authors:  Robson Francisco Carvalho; Antonio Carlos Cicogna; Gerson Eduardo Rocha Campos; Francis da Silva Lopes; Mário Mateus Sugizaki; Célia Regina Nogueira; Maeli Dal Pai-Silva
Journal:  Int J Exp Pathol       Date:  2006-06       Impact factor: 1.925

4.  Expression of foetal type acetylcholine receptor is restricted to type 1 muscle fibres in human neuromuscular disorders.

Authors:  Stefan Gattenlöhner; Christiane Schneider; Claus Thamer; Rüdiger Klein; Wolfgang Roggendorf; Frank Gohlke; Caroline Niethammer; Stefanie Czub; Angela Vincent; Hans-Konrad Müller-Hermelink; Alexander Marx
Journal:  Brain       Date:  2002-06       Impact factor: 13.501

5.  Skeletal muscle abnormalities in rats with experimentally induced heart hypertrophy and failure.

Authors:  Palmira Bernocchi; Anna Cargnoni; Giorgio Vescovo; Luciano Dalla Libera; Giovanni Parrinello; Antonella Boraso; Claudio Ceconi; Roberto Ferrari
Journal:  Basic Res Cardiol       Date:  2003-03       Impact factor: 17.165

6.  Myosin heavy chain expression and atrophy in rat skeletal muscle during transition from cardiac hypertrophy to heart failure.

Authors:  Robson Francisco Carvalho; Antonio Carlos Cicogna; Gerson Eduardo Rocha Campos; Jeane Marlene Fogaça De Assis; Carlos Roberto Padovani; Marina Politi Okoshi; Maeli Dal Pai-Silva
Journal:  Int J Exp Pathol       Date:  2003-08       Impact factor: 1.925

7.  Skeletal muscle myosin heavy chain expression in rats with monocrotaline-induced cardiac hypertrophy and failure. Relation to blood flow and degree of muscle atrophy.

Authors:  G Vescovo; C Ceconi; P Bernocchi; R Ferrari; U Carraro; G B Ambrosio; L D Libera
Journal:  Cardiovasc Res       Date:  1998-07       Impact factor: 10.787

8.  Abnormalities of skeletal muscle in patients with chronic heart failure.

Authors:  D P Lipkin; D A Jones; J M Round; P A Poole-Wilson
Journal:  Int J Cardiol       Date:  1988-02       Impact factor: 4.164

9.  Apoptosis and atrophy in rat slow skeletal muscles in chronic heart failure.

Authors:  L D Libera; R Zennaro; M Sandri; G B Ambrosio; G Vescovo
Journal:  Am J Physiol       Date:  1999-11

10.  Neural factors regulate AChR subunit mRNAs at rat neuromuscular synapses.

Authors:  V Witzemann; H R Brenner; B Sakmann
Journal:  J Cell Biol       Date:  1991-07       Impact factor: 10.539

View more
  4 in total

1.  Neuromuscular junctions (NMJs): ultrastructural analysis and nicotinic acetylcholine receptor (nAChR) subunit mRNA expression in offspring subjected to protein restriction throughout pregnancy.

Authors:  Paula Aiello Tomé de Souza Castro; Ludimila Canuto Faccioni; Patrícia Aline Boer; Robson Francisco Carvalho; Selma Maria Michelin Matheus; Maeli Dal-Pai-Silva
Journal:  Int J Exp Pathol       Date:  2017-05-25       Impact factor: 1.925

2.  cAMP-PKA-CaMKII signaling pathway is involved in aggravated cardiotoxicity during Fuzi and Beimu Combination Treatment of Experimental Pulmonary Hypertension.

Authors:  Pengwei Zhuang; Yingying Huang; Zhiqiang Lu; Zhen Yang; Liman Xu; Fengjiao Sun; Yanjun Zhang; Jinao Duan
Journal:  Sci Rep       Date:  2016-10-14       Impact factor: 4.379

3.  Reaching task performance is associated to neuromuscular junction adaptations in rats with induced diabetes mellitus.

Authors:  Y C Estrada-Bonilla; P A T S Castro; G L F Luna; A B A Souza; G S Santos; T F Salvini; A M O Leal; T L Russo
Journal:  Braz J Med Biol Res       Date:  2020-06-03       Impact factor: 2.590

4.  Neuromuscular junctions are stable in patients with cancer cachexia.

Authors:  Ines Boehm; Janice Miller; Thomas M Wishart; Stephen J Wigmore; Richard Je Skipworth; Ross A Jones; Thomas H Gillingwater
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.